The latest news and updates from the BSGCT Dear %FirstName%, We are bringing back the “researcher of the month” section in our newsletters. This section includes a brief Q&A to a different member of our community each month so we…
RareBeacon’s Drug Repurposing for Rare Diseases 2022 is shifting its programme to match the new Drug Repurposing landscape. Instead of inspiring attendees with case studies on how you could succeed with a Repurposing project, the conference is taking a more…
Authors: Rosie Mundy and Aimee Lucignoli Viruses have a long history of causing illness and disease, but a recent BSGCT blog post highlighted how they can also be used for good (https://www.bsgct.org/post/making-gene-and-cell-therapy-possible-viruses). By engineering, mutating and even a bit of…
The latest news and updates from the BSGCT Dear %FirstName%, We hope you are well and enjoying the summer. We are very pleased to announce that BSGCT will be running its Science Writing Competition again this year. The competition will…
At the AGM in March 2012, the Society voted unanimously for a name change to British Society for Gene and Cell Therapy (BSGCT) to reflect the increasing synergy between the field of gene therapy and cell biology, in particular stem…
Following the success of our recent BSGCT conference at RHUL 2013, the BSGCT are delighted that the forthcoming annual conference for 2014 which focused on “Advances in Immunology for Gene and Cell Therapy” and held at The Institute of Child…
This was a full BSGCT Annual Conference (including a Public Education Day, scientific education session, main 48 hr BSGCT meeting, satellite Gene, Cell and Molecular Therapies for Inherited Metabolic Disease Meeting and for the first time a joint meeting with…
The 13th annual meeting of the British Society for Gene and Cell Therapy (BSGCT) reflected the huge interest currently being generated in use of adeno-associated virus as a therapeutic vector. The purpose of the shorter 1 day meeting was to…
BSGCT Annual Conference UK Regenerative Medicine Platform Joint Meeting 2017 It was our great pleasure to welcome delegates to the British Society for Gene and Cell Therapy Annual Conference and UK Regenerative Medicine Platform Joint Meeting which was held at…
Lentiviral and other retroviral vectors in 2018: Applications, production and vector design relevant for translation into human Lentviral and retroviral vectors are at the forefront of advanced therapeutic medicinal product (ATMP) development. The 1-day conference on Friday 27th April 2018…